These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34754424)

  • 1. Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease.
    Torra R; Pérez-Gómez MV; Furlano M
    Clin Kidney J; 2021 Nov; 14(11):2281-2284. PubMed ID: 34754424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
    Hoover E; Holliday V; Merullo N; Oberdhan D; Perrone RD; Rusconi C; Park M; Phadnis MA; Thewarapperuma N; Dahl NK
    Kidney Med; 2024 May; 6(5):100813. PubMed ID: 38689835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
    Cho Y; Tong A; Craig JC; Mustafa RA; Chapman A; Perrone RD; Ahn C; Fowler K; Torres V; Gansevoort RT; Ong ACM; Coolican H; Tze-Wah Kao J; Harris T; Gutman T; Shen JI; Viecelli AK; Johnson DW; Au E; El-Damanawi R; Logeman C; Ju A; Manera KE; Chonchol M; Odland D; Baron D; Pei Y; Sautenet B; Rastogi A; Sharma A; Rangan G;
    Am J Kidney Dis; 2021 Feb; 77(2):255-263. PubMed ID: 32771648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.
    Natale P; Perrone RD; Tong A; Harris T; Hannan E; Ju A; Burnette E; Casteleijn NF; Chapman A; Eastty S; Gansevoort RT; Hogan M; Horie S; Knebelmann B; Lee R; Mustafa RA; Sandford R; Baumgart A; Craig JC; Rangan GK; Sautenet B; Viecelli AK; Amir N; Evangelidis N; Guha C; Logeman C; Manera K; Matus Gonzalez A; Howell M; Strippoli GFM; Cho Y
    Clin Kidney J; 2022 Mar; 15(3):407-416. PubMed ID: 35211300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease.
    El-Damanawi R; Lee M; Harris T; Cowley LB; Scholtes I; Bond S; Sandford RN; Wilkinson IB; Casteleijn NF; Hogan MC; Karet Frankl FE; Hiemstra TF
    Clin Kidney J; 2021 Nov; 14(11):2338-2348. PubMed ID: 34754429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
    Natale P; Hannan E; Sautenet B; Ju A; Perrone RD; Burnette E; Casteleijn N; Chapman A; Eastty S; Gansevoort R; Hogan M; Horie S; Knebelmann B; Lee R; Mustafa RA; Sandford R; Baumgart A; Tong A; Strippoli GFM; Craig JC; Rangan GK; Cho Y
    PLoS One; 2021; 16(5):e0252479. PubMed ID: 34043715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
    Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
    Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
    Sautenet B; Cho Y; Gutman T; Rangan G; Ong A; Chapman AB; Ahn C; Coolican H; Tze-Wah Kao J; Fowler K; Gansevoort RT; Geneste C; Perrone RD; Harris T; Torres VE; Pei Y; Craig JC; Tong A;
    Am J Kidney Dis; 2020 Aug; 76(2):213-223. PubMed ID: 32171640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
    Oberdhan D; Cole JC; Atkinson MJ; Krasa HB; Davison SN; Perrone RD
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):213-222. PubMed ID: 36754008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease.
    Oberdhan D; Yarlas A; Bjorner JB; Krasa H
    Kidney Med; 2024 Jan; 6(1):100755. PubMed ID: 38192435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
    Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
    Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
    Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
    BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.
    Xue C; Zhou CC; Wu M; Mei CL
    Kidney Dis (Basel); 2016 Oct; 2(3):111-119. PubMed ID: 27921038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership.
    Harris T; Bridges HR; Brown WD; O'Brien NL; Daly AC; Jindal BK; Mundy GS; Ong A; Power AJ; Sandford RN; Sayer J; Simms RJ; Wilson PD; Winyard PJD; Tarpey M
    BMJ Open; 2022 Jun; 12(6):e055780. PubMed ID: 35705349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic Kidney Disease Drug Development: A Conference Report.
    Liebau MC; Mekahli D; Perrone R; Soyfer B; Fedeles S
    Kidney Med; 2023 Mar; 5(3):100596. PubMed ID: 36698747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease: a cross-sectional study.
    Chasan O; Mirioglu S; Artan AS; Gursu M; Kazancioglu R; Elcioglu OC
    Clin Exp Nephrol; 2023 Nov; 27(11):912-918. PubMed ID: 37493903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
    Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
    Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Smith KA; Thompson AM; Baron DA; Broadbent ST; Lundstrom GH; Perrone RD
    Am J Kidney Dis; 2019 Apr; 73(4):533-541. PubMed ID: 30600104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.